Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 6,835 | 157,957 | 27,230 | 26,460 | 29,378 |
| Gross Profit | 6,835 | 157,957 | 27,230 | 26,460 | 29,378 |
| Operating Expenses | 130,407 | 139,923 | 82,622 | 81,354 | 75,112 |
| Operating Income | -123,572 | 18,034 | -55,392 | -54,894 | -45,734 |
| Other Income | 2,802 | 3,293 | 3,678 | 1,769 | 2,643 |
| Pre-tax Income | -120,770 | 21,327 | -51,714 | -53,125 | -43,091 |
| Income Tax | -6,264 | 194 | 259 | 30 | 82 |
| Net Income Continuous | -114,506 | 21,133 | -51,973 | -53,155 | -43,173 |
| Net Income | $-114,506 | $21,133 | $-51,973 | $-53,155 | $-43,173 |
| EPS Basic Total Ops | -0.66 | 0.13 | -0.32 | -0.34 | -0.29 |
| EPS Basic Continuous Ops | -0.66 | 0.13 | -0.32 | -0.34 | -0.29 |
| EPS Diluted Total Ops | -0.66 | 0.12 | -0.32 | -0.34 | -0.29 |
| EPS Diluted Continuous Ops | -0.66 | 0.12 | -0.32 | -0.34 | -0.29 |
| EBITDA(a) | $-66,860 | $60,705 | $-50,870 | $-50,244 | $-40,688 |